New FDA approval expands use of AstraZeneca's Faslodex for women with HR+, HER2- meta - HER2 Support Group Forums

		HER2 Support Group Forums > General Cancer News
New FDA approval expands use of AstraZeneca's Faslodex for women with HR+, HER2- meta

General Cancer News Latest Breast Cancer News from Moreover Technologies

Reply

03-07-2016, 06:31 AM	#1
News Senior Member Join Date: Oct 2007 Posts: 18,986	New FDA approval expands use of AstraZeneca's Faslodex for women with HR+, HER2- meta AstraZeneca today announced that the US Food and Drug Administration has approved a new indication in the US, expanding the use of Faslodex (fulvestrant) to include use in combination with Ibrance (palbociclib). More...

Reply

« Previous Thread | Next Thread »

Posting Rules
You may not post new threads You may not post replies You may not post attachments You may not edit your posts BB code is On Smilies are On [IMG] code is On HTML code is Off Forum Rules

All times are GMT -7. The time now is 10:28 AM.

free webpage hit counter